SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,960,630 | +46.8% | 49,172 | +38.7% | 0.00% | +50.0% |
| Q2 2023 | $4,059,505 | -33.2% | 35,448 | -19.7% | 0.00% | -33.3% |
| Q1 2023 | $6,080,922 | +62.1% | 44,119 | +50.0% | 0.00% | +50.0% |
| Q4 2022 | $3,751,435 | +10.1% | 29,417 | -5.3% | 0.00% | 0.0% |
| Q3 2022 | $3,406,776 | +33.1% | 31,053 | -6.7% | 0.00% | 0.0% |
| Q2 2022 | $2,560,372 | +12.6% | 33,293 | +15.0% | 0.00% | +100.0% |
| Q1 2022 | $2,274,267 | +755.0% | 28,953 | +1756.0% | 0.00% | – |
| Q4 2020 | $266,000 | +21.5% | 1,560 | 0.0% | 0.00% | – |
| Q3 2020 | $219,000 | -13.8% | 1,560 | 0.0% | 0.00% | – |
| Q2 2020 | $254,000 | +5.4% | 1,560 | -16.4% | 0.00% | – |
| Q4 2019 | $241,000 | -12.7% | 1,866 | +2.6% | 0.00% | – |
| Q2 2019 | $276,000 | +5.7% | 1,819 | +12.6% | 0.00% | – |
| Q3 2018 | $261,000 | +7.9% | 1,615 | -12.0% | 0.00% | – |
| Q2 2018 | $242,000 | -92.8% | 1,835 | -95.9% | 0.00% | -100.0% |
| Q1 2018 | $3,353,000 | +29.7% | 45,257 | -2.6% | 0.00% | +33.3% |
| Q4 2017 | $2,585,000 | +27.0% | 46,467 | +3.6% | 0.00% | +50.0% |
| Q3 2017 | $2,036,000 | +50.3% | 44,863 | +11.6% | 0.00% | 0.0% |
| Q2 2017 | $1,355,000 | +18.1% | 40,188 | +3.7% | 0.00% | +100.0% |
| Q1 2017 | $1,147,000 | +22.7% | 38,753 | +13.7% | 0.00% | 0.0% |
| Q4 2016 | $935,000 | -48.0% | 34,077 | +16.4% | 0.00% | -66.7% |
| Q3 2016 | $1,797,000 | +222.0% | 29,275 | -0.0% | 0.00% | +200.0% |
| Q2 2016 | $558,000 | -2.6% | 29,280 | -1.5% | 0.00% | – |
| Q1 2016 | $573,000 | -45.6% | 29,725 | +9.0% | 0.00% | -100.0% |
| Q4 2015 | $1,053,000 | +21.5% | 27,271 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $867,000 | +7.2% | 26,997 | +1.6% | 0.00% | 0.0% |
| Q2 2015 | $809,000 | +120.4% | 26,570 | -3.9% | 0.00% | – |
| Q1 2015 | $367,000 | -4.4% | 27,642 | +4.1% | 0.00% | -100.0% |
| Q4 2014 | $384,000 | -31.9% | 26,547 | -0.8% | 0.00% | 0.0% |
| Q3 2014 | $564,000 | -27.5% | 26,748 | +2.5% | 0.00% | 0.0% |
| Q2 2014 | $778,000 | +13.1% | 26,094 | -8.9% | 0.00% | 0.0% |
| Q1 2014 | $688,000 | +30.3% | 28,630 | +10.5% | 0.00% | 0.0% |
| Q4 2013 | $528,000 | -54.5% | 25,911 | +5.5% | 0.00% | -50.0% |
| Q3 2013 | $1,160,000 | +20.3% | 24,561 | -3.0% | 0.00% | 0.0% |
| Q2 2013 | $964,000 | – | 25,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |